Hyperion DeFi Stock (NASDAQ:HYPD)

Revenue Ownership Financials Chart Transcripts

Previous Close

$3.26

52W Range

$2.49 - $16.12

50D Avg

$3.49

200D Avg

$4.50

Market Cap

$14.27M

Avg Vol (3M)

$595.08K

Beta

2.50

Div Yield

HYPD Company Profile

Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Jul 02, 2025

Website

HYPD Performance

HYPD Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$57.34K	$3.79K	-
Operating Income	$-48.74M	$-25.41M	$-26.91M
Net Income	$-49.82M	$-27.26M	$-28.01M
EBITDA	$-46.21M	$-24.11M	$-26.32M
Basic EPS	$-59.81	$-53.15	$-66.40
Diluted EPS	$-59.81	$-53.15	$-66.40

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 14, 26 | 12:00 AM

Q3 25Nov 14, 25 | 5:00 PM

Peer Comparison

Ticker	Company
PIII	P3 Health Partners Inc.
MURA	Mural Oncology plc
NMTC	NeuroOne Medical Technologies Corporation
JSPR	Jasper Therapeutics, Inc.
BTAI	BioXcel Therapeutics, Inc.
VRCA	Verrica Pharmaceuticals Inc.
MODD	Modular Medical, Inc.
ECOR	electroCore, Inc.
RBOT	Vicarious Surgical Inc.